Oakland - California, U.S.A. - Canada
Software (Web Marketplace Saas..) • Education • BioTech • FinTech (& Financials services) • Woman Focused • Productivity
Dr. Brian Dixon serves as Venture Partner at Elm Street Ventures. He also serves as the Chief Executive Officer of BioRelix, Inc. Prior to joining BioRelix in October 2007, Dr. Dixon served as Vice President with Bayer HealthCare in West Haven Connecticut. In that position, he led a multi-disciplinary organization of up to 130 employees that delivered state-of-the-art expertise in oncology biomarker discovery, new lead discovery, research drug formulation, pharmacokinetics and drug metabolism to Bayer's global R&D business. In addition, he held leadership roles in R&D licensing initiatives, strategic alliances and cross divisional collaborations in translational medicine. From 1998 to 2001, Dr. Dixon directed Bayer drug discovery efforts in both the Osteoporosis and Oncology therapeutic areas. He serves as a Director of BioRelix, Inc. Dr. Dixon was an undergraduate at the University of Michigan. He received his Ph.D. in Organic Chemistry from the Massachusetts Institute of Technology and completed post-doctoral training at Harvard University.
New York - Seattle - Washington, U.S.A.
BioTech • Businesses Solutions • A.I. (& Big Data) • Robotics
General Partner at IA Ventures
What I look for
Pre-product market fit companies making the world suck less by delivering magical-seeming solutions to important and difficult problems. And appeal to a rational economic buyer.
Founders who are customer domain experts with a formidable strategic understanding of, and an ambitious non-obvious take on, a fast growing market.
Companies benefiting from a massive fundamental trend. Ones where the market will continue to blossom over the next 10+ years. For example:
DataDog and DigitalOcean benefit from the incredible growth of new software developers,
Kepler benefits from the burgeoning space economy & software-defined satellites,
DataRobot benefits from the importance of ML and the desire to democratize it,
Coiled benefits from Python becoming the defacto language of data science/engineering,
Canvas benefits from the move to value-based health care, and
Vectra benefits from the rise of AI, the move to the cloud, and the increasing sophistication of security attacks.
Companies with audacious visions that can deliver an MVP and have many collisions with the market in the 12 months following our initial investment because distribution matters as much as product. Ones that can get to fast-growing, high-margin, scalable, and repeatable revenue within 18 months.
Companies that have a thesis about how they can be a 70%+ gross margin business with an accelerating advantage that enable them to capture the majority of the market and resulting economics.
Founders that display clarity, courage, & urgency (clarity of speech == clarity of thought). Ones who are relentlessly resourceful and can attract the talent to achieve the vision.
How I like to invest
Provide enough runway. 24+ months of capital (thoughts on burn and team size at the seed stage) to build team, product, demonstrate the irrefutable product-market fit needed to raise the next round from a great investor.
Have enough conviction to do the whole round. No lead investor should make founders scavenge to fill out the round.
Value great syndicate members over ownership. The right syndicate can change the complexion of a company. Bottom line is the founder has the final say as to the right raise and right syndicate — keeping in mind it’s in both our interests to have a small focused group of truly helpful investors.
Hold an additional amount in reserve from the outset in case the company needs a bridge to demonstrate product-market fit. This falls under the responsibility of a true lead investor.
Invest in only a handful of companies a year. New investments should never be “options” or “lottery tickets.” Every investment I make has the potential to change the world, be a legendary company, and return our fund many times over.
Keep it simple (e.g. post-money SAFE) and expect that the time from signed term sheet to money in the bank will be less than 2 weeks.
Pay my own legal fees.
How I like to work with companies
Earn the trust of founders. Founders who believed in me enough to let me invest in their company.
Do no harm. The singular focus of a seed-stage company is finding irrefutable product-market fit. Investors can and do help, but most important is to ensure they don’t randomize founders. Founders know their business better than anyone.
Be an accountability partner. This has an outsize effect on success.
Be aligned. Every round of funding is an experiment. It is important to be explicit about, constantly assess, and evolve the hypotheses that are being tested. The company and its investors must be aligned prior to an investment. I’ve found that the best way to achieve this is for the founders and investors to explicitly define and agree upon the hypotheses being tested with this round of funding (here is an example of a hypothesis document ). That is not to say things won’t change, but it’s much easier when both parties are starting from a place of mutual understanding.
How I like to communicate
Be open. Send me anything you think is helpful or useful. When in doubt, send it. I read every email — if I have something of value to say I’ll respond, if not I won’t. The more information we share, the better we can work together.
I’ve found that the best entrepreneurs send out monthly updates.
Be candid. If I’ve done something that you want me to stop doing, keep doing, or start doing — let me know. I’d rather you be honest with me and tell me I screwed up than keep it to yourself. It makes me better and builds trust between us.
I’m your investor. I believe in you. I want you to succeed. I’ve seen it all (ducks!). You don’t need to market to me.
What I hope for
While each company has its own path to success, patterns do stand out. Generally, within 18 months after our initial investment, the best companies have built the right team, have the product in market and have demonstrated conclusive and irrefutable product-market fit (if you are not sure you have it, you likely don’t).
Once a company has demonstrated product-market fit, actively help raise the next round. Work closely with companies to refine the pitch (here is some great advice). Introduce them to the best VCs.
Invest my pro-rata in subsequent rounds of those companies that have demonstrated success. On average we invest somewhere between $6 and $10M over the life of the best companies in our portfolio. And those companies return 10x++ our total investment.
San Francisco Bay Area, U.S.A. - China
BioTech • Hardware (& Manufacturing) • HealthTech (& Fitness) • Robotics • Aerospace (& Defense) • Healthcare (& Wellness) • Consumer
Cyril Ebersweiler serves as Managing Director, HAX and General Partner at SOSV. A hardware investor, visionary and serial entrepreneur, Cyril was SOSV's first general partner to run an accelerator, starting Chinaccelerator, the first mentorship-driven seed-funding program in China. He then went on to found HAX - the world's first and largest hardware accelerator - in 2012, along with HAX China and HAX Growth. Cyril is a mentor to Techstars and 500 Startups, and a founding member of the Global Accelerator Network. He is one of the world's most prolific investors in the hardware space, with 80+ investments. Cyril is a frequent speaker at events such as TechCrunch Disrupt, Makercon, Solidcon, Pioneers, The New Context Conference, AdTech, GMIC, and many others. He is an occasional guest writer at Techcrunch, and has been featured in The Economist, Popular Mechanics, The New York Times, Bloomberg, Huffington Post, Wired and more. He served as the Board Member at Nextly. He serves as Board Member in Formlabs.
San Francisco Bay Area - California, U.S.A. - Canada
Software (Web Marketplace Saas..) • BioTech • AgroTech • Hardware (& Manufacturing) • CleanTech • Blockchain (& Cryptos) • Impact • Robotics • Mobility
General Partner at FTW Ventures, improving the worldwide Food System
Most Interested In
FTW Ventures invests in innovations for the Food System, including Ag, Food, Consumer & Heath Tech. We look for great teams doing something revolutionary.
Not Interested In
Anything outside our core sectors - Ag, Food & Health
Advisor/Investor @teforia @nomiku @gelzen @ProperFood @lemnoslabs @indiebio @timeful (acq @google) @posterous (acq @twitter). CS @cornell-university
Boston Massachusetts - Seattle Washington - Pasadena, U.S.A.
BioTech • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Consumer • Pharmaceutical (& Medicine)
Launched in November 2011, the Harvard Innovation Lab (i-lab) serves as a resource for students from across Harvard interested in entrepreneurship and innovation. The programming offered by the i-lab is designed to help students grow their ventures at any stage of development and covers a wide range of disciplines. The i-lab fosters collaboration among Harvard students, faculty, entrepreneurs, and members of the Allston and Greater Boston communities. Community members are invited to attend many of the events hosted at the i-lab, to stop at the InnoBreak Cafe (offering coffee and snacks), and utilize the Center's community lobby open workspace and WiFi. For Harvard student led teams whose ventures have progressed to a more advanced stage, the i-lab offers a Venture Incubation Program (VIP) during the Spring, Summer, and Fall of each calendar year.
Ontario California - Toronto Ontario - Toronto (Ontario) - Toronto (), U.S.A.
PropTech • BioTech • AgroTech • Hardware (& Manufacturing) • Entertainment (& Sports) • Food & Beverage • Impact • Medical Devices (& Hospital Services) • Real Estate (& Construction) • Mobility • Consumer
Jesse Rasch is a Co-Founder and serves as Chairman & Chief Executive Officer at Hedgewood. He is the co-founder and past Chairman & CEO of WebHosting.com and InQuent Technologies. He co-founded CareGuide. InQuent provides private label hosting solutions to telecommunications customers including Bell Canada, KPN, Telecom New Zealand, PCCW, AT&T, Comcast, & Cox Communications. WebHosting.Com was one of the largest business web hosting companies in the world. In 2000, Rasch sold InQuent and WebHosting.Com to AT&T. In 2002, Rasch orchestrated a management team acquisition of InQuent from AT&T. Rasch successfully sold InQuent once more in 2003. InQuent was merged with Network Solutions and is now part of publicly traded web.com. Rasch is widely credited with establishing the white label web hosting market segment that is a significant component of the $95 billion annual web hosting market. VerticalScope, which Rasch co-founded, develops and acquires online media and community properties. VerticalScope's network of websites is visited by over 85,000,000 people per month. VerticalScope's automotive publishing division, the Modified Automotive Group, was acquired by KKR / Primedia in 2007. Torstar acquired 56% of VerticalScope in 2015. Rasch is a proponent of venture philanthropy and is active in encouraging entrepreneurs to participate in strategic philanthropy. He established the Jesse & Julie Rasch Foundation in 2000 to invest in causes that reflect Rasch's broad charitable interests. In 2001, Rasch was awarded the Ernst & Young Entrepreneur of the Year award. He has been featured in Time Magazine, The Globe & Mail, Canadian Business, The National Post, Network World, Macleans, and on CBC, CTV, Global, City-TV, BNN, and many other print, televised, and radio media. He was a founding member of the Canadian E-Business Opportunities Roundtable, a joint private and public sector advisory group on e-business in Canada.
San Francisco Bay Area - Westport - Connecticut, U.S.A.
Software (Web Marketplace Saas..) • BioTech • Businesses Solutions • Retail (& E-Commerce) • A.I. (& Big Data) • Blockchain (& Cryptos) • Future Of Work • Nanotechnology • Consumer • Woman Focused
Most Interested In
2.12 Angel's focus is on Enterprise Technology. Our goal is to be the "The highest value-add to Founders per dollar invested" - we invest fast (2 meetings, answer at 12 the next day) and bring a lot of services we pay for to support Founders (exec coach, CTO mentor, Sales coaching, Culture and value program, Founder concierge etc.). We invest 100k and made 30 investments in 2021
Not Interested In
We don't invest in consumer, clean energy, and pharma/biotech as those sectors are clearly outside of my 'circle of competence'
Paris, France
Software (Web Marketplace Saas..) • Education • BioTech • Cosmetics (& Fashion) • CleanTech • A.I. (& Big Data) • HealthTech (& Fitness) • Autonomous vehicles (& Cars) • Food & Beverage • Logistics (& Distribution) • Healthcare (& Wellness) • Consumer
Entrepreneur & Investor
Tech entrepreneur | Early Stage Investor | Venture Partner
Nicolas Douay is a Co-Founder and serves as a Chief Operating Officer and General Manager at KelDoc. After five in a large international consulting firm in management information systems, Nicolas decided to start Keldoc.
Campbell, California, United States
Software (Web Marketplace Saas..) • IT (& TMT) • BioTech • Hardware (& Manufacturing) • Sales (& Marketing) • Insurance (& InsurTech) • Medical Devices (& Hospital Services) • Mobile
Co-Founder & Managing Director at BreakawayGrowth Fund
Co-Founder & Managing Director at BreakawayGrowth Fund